Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sam who wrote (5615)	11/2/1998 11:32:00 AM
From: Izzy	Read Replies (2) of 6136

The way I read the drug instructions for Agenerase (amprenavir) it's eight 150 mg caps BID (not 2 BID). Maybe, if you're unsure of the market status of new HIV drugs, you should consider buying VRTX and GLX (not me). I really don't think that Viracept has any serious competition whatsoever for some time to come. And, if AGPH ever gets into the 20s again, I'm loading up (I didn't do it last time but I'll sure do it this next time, if it actually happens, which I doubt). But, hey, I'm only a small fish. What do I know? However, there is nothing so far to make me change my mind in prescribing Viracept.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next